NVAX Chart
See on advanced chart >
About
Novavax, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The company's vaccine technology platform is based on proprietary recombinant...
Read More
- HighlightA world's leading COVID-19 vaccine development company
- ExchangeNASDAQ
- Listing Date07/01/2001
- Established DateInvalid Date
- Full-time Employees1,543
- Address20 Firstfield Road Gaithersburg Maryland 20878
- Tel1-240-2682000
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology